(Q35597981)

English

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

scientific article published on 14 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Tack

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

S Müller-Lissner

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

P Bytzer

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

R Corinaldesi

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

L Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A Viegas

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

S Schnekenbuehl

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C Dunger-Baldauf

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

P Rueegg

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

14 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1707-1713

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

EQ-5D: a measure of health status from the EuroQol Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

Management of the irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

Adequate relief as an endpoint in clinical trials in irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

Review article: irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774790

12 July 2018

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16020489

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irritable bowel syndrome symptom patterns: frequency, duration, and severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16020489

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The validity and accuracy of the Work Productivity and Activity Impairment questionnaire--irritable bowel syndrome version (WPAI:IBS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16020489

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using the number needed to treat in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16020489

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.2005.070789

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

release_5t25es6j5nboxfzkgcplgopo3m

1 reference

https://api.fatcat.wiki/v0/release/5t25es6j5nboxfzkgcplgopo3m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35597981&oldid=1838804055"